{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:29:10Z","timestamp":1784896150392,"version":"3.55.0"},"publisher-location":"Berlin, Heidelberg","reference-count":101,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540857716","type":"print"},{"value":"9783540857723","type":"electronic"}],"license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-3-540-85772-3_1","type":"book-chapter","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T09:10:18Z","timestamp":1303290618000},"page":"3-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["History of Multiple Myeloma"],"prefix":"10.1007","author":[{"given":"Robert A.","family":"Kyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Steensma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,19]]},"reference":[{"key":"1_CR1_1","first-page":"186","volume":"23","author":"W Adams","year":"1872","unstructured":"Adams W (1872) Mollities ossium. Trans Pathol Soc Lond 23:186\u2013187","journal-title":"Trans Pathol Soc Lond"},{"key":"1_CR2_1","first-page":"2615","volume":"59","author":"J Adams","year":"1999","unstructured":"Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S, Elliott PJ (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 59:2615\u20132622","journal-title":"Cancer Res"},{"key":"1_CR3_1","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1001\/jama.208.9.1680","volume":"208","author":"R Alexanian","year":"1969","unstructured":"Alexanian R, Haut A, Khan AU, Lane M, McKelvey EM, Migliore PJ, Stuckey WJ Jr, Wilson HE (1969) Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens. JAMA 208:1680\u20131685","journal-title":"JAMA"},{"key":"1_CR4_1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0140-6736(47)90375-9","volume":"2","author":"N Alwall","year":"1947","unstructured":"Alwall N (1947) Urethane and stilbamidine in multiple myeloma: report on two cases. Lancet 2:388\u2013389","journal-title":"Lancet"},{"key":"1_CR5_1","first-page":"233","volume":"38","author":"MI Arinkin","year":"1929","unstructured":"Arinkin MI (1929) Die intravitale Untersuchungsmethodik des Knochenmarks. Folia Haematologie 38:233\u2013240","journal-title":"Folia Haematologie"},{"key":"1_CR6_1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood.V70.3.869.869","volume":"70","author":"B Barlogie","year":"1987","unstructured":"Barlogie B, Alexanian R, Dicke KA, Zagars G, Spitzer G, Jagannath S, Horwitz L (1987) High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood 70:869\u2013872","journal-title":"Blood"},{"key":"1_CR7_1","first-page":"119","volume":"33","author":"S Bayne-Jones","year":"1922","unstructured":"Bayne-Jones S, Wilson DW (1922) Immunological reactions of Bence Jones proteins. II. Differences between Bence Jones proteins from various sources. Bull Johns Hopkins Hosp 33:119\u2013125","journal-title":"Bull Johns Hopkins Hosp"},{"key":"1_CR8_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.1947.02880030001001","volume":"133","author":"ED Bayrd","year":"1947","unstructured":"Bayrd ED, Heck FJ (1947) Multiple myeloma: a review of eighty-three proved cases. JAMA 133:147\u2013157","journal-title":"JAMA"},{"key":"1_CR9_1","volume-title":"On gravel, calculus and gout; chiefly an application of Professor Liebig\u2019s physiology to the prevention and cure of these diseases","author":"H Bence Jones","year":"1842","unstructured":"Bence Jones H (1842) On gravel, calculus and gout; chiefly an application of Professor Liebig\u2019s physiology to the prevention and cure of these diseases. Taylor & Walton, London"},{"key":"1_CR10_1","volume-title":"On the state in which the uric acid exists in the urine","author":"H Bence Jones","year":"1845","unstructured":"Bence Jones H (1845) On the state in which the uric acid exists in the urine. R. Kinder, London"},{"key":"1_CR11_1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0140-6736(02)86528-X","volume":"2","author":"H Bence Jones","year":"1847","unstructured":"Bence Jones H (1847) Chemical pathology. Lancet 2:88\u201392","journal-title":"Lancet"},{"key":"1_CR12_1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1098\/rstl.1848.0003","volume":"138","author":"H Bence Jones","year":"1848","unstructured":"Bence Jones H (1848) On the new substance occurring in the urine of a patient with mollities ossium. Philos Trans R Soc Lond 138:55\u201362","journal-title":"Philos Trans R Soc Lond"},{"key":"1_CR13_1","volume-title":"The life and letters of Faraday","author":"H Bence Jones","year":"1870","unstructured":"Bence Jones H (1870) The life and letters of Faraday. J. B. Lippincott, Philadelphia"},{"key":"1_CR14_1","volume-title":"An autobiography (with elucidations at later dates by his son, A.B. Bence Jones)","author":"H Bence Jones","year":"1929","unstructured":"Bence Jones H (1929) An autobiography (with elucidations at later dates by his son, A.B. Bence Jones). Crusha & Sons, London (privately printed)"},{"key":"1_CR15_1","first-page":"87","volume":"21","author":"DE Bergsagel","year":"1962","unstructured":"Bergsagel DE, Sprague CC, Austin C, Griffith KM (1962) Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806). Cancer Chemother Rep 21:87\u201399","journal-title":"Cancer Chemother Rep"},{"key":"1_CR16_1","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/j.1749-6632.1958.tb42675.x","volume":"68","author":"N Blokhin","year":"1958","unstructured":"Blokhin N, Larionov L, Perevodchikova N, Chebotareva L, Merkulova N (1958) Clinical experiences with sarcolysin in neoplastic diseases. Ann NY Acad Sci 68:1128\u20131132","journal-title":"Ann NY Acad Sci"},{"key":"1_CR17_1","first-page":"83","volume":"1","author":"SR Cajal","year":"1896","unstructured":"Cajal SR (1896) Estudios histologicos sobre los tumores epiteliales. Rev Trimest Microgr 1:83\u2013111","journal-title":"Rev Trimest Microgr"},{"key":"1_CR18_1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/ijc.20610","volume":"113","author":"LL Capasso","year":"2005","unstructured":"Capasso LL (2005) Antiquity of cancer. Int J Cancer 113:2\u201313","journal-title":"Int J Cancer"},{"key":"1_CR19_1","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/0002-9343(77)90543-5","volume":"63","author":"DC Case Jr","year":"1977","unstructured":"Case DC Jr, Lee DJ III, Clarkson BD (1977) Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol. Am J Med 63:897\u2013903","journal-title":"Am J Med"},{"key":"1_CR20_1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0092-8674(94)90396-4","volume":"79","author":"A Ciechanover","year":"1994","unstructured":"Ciechanover A (1994) The ubiquitin-proteasome proteolytic pathway. Cell 79:13\u201321","journal-title":"Cell"},{"key":"1_CR21_1","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"RJ D\u2019Amato","year":"1994","unstructured":"D\u2019Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91:4082\u20134085","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR22_1","first-page":"1","volume":"3","author":"WH Day","year":"1870","unstructured":"Day WH (1870) On the hypophosphites of iron, quinine, and strychnia in cases of general debility and nervous exhaustion. Trans Clin Soc Lond 3:1\u20137","journal-title":"Trans Clin Soc Lond"},{"key":"1_CR23_1","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1056\/NEJMoa070594","volume":"357","author":"M Dimopoulos","year":"2007","unstructured":"Dimopoulos M, Spencer A, Attal M, Prince HM, Harousseau JL, Dmoszynska A, San Miguel J, Hellmann A, Facon T, Foa R, Corso A, Masliak Z, Olesnyckyj M, Yu Z, Patin J, Zeldis JB, Knight RD (2007) Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. N Engl J Med 357:2123\u20132132","journal-title":"N Engl J Med"},{"key":"1_CR24_1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1084\/jem.116.2.207","volume":"116","author":"GM Edelman","year":"1962","unstructured":"Edelman GM, Gally JA (1962) The nature of Bence-Jones proteins. Chemical similarities to polypetide chains of myeloma globulins and normal gamma-globulins. J Exp Med 116:207\u2013227","journal-title":"J Exp Med"},{"key":"1_CR25_1","first-page":"1269","volume":"76","author":"A Fefer","year":"1986","unstructured":"Fefer A, Cheever MA, Greenberg PD (1986) Identical-twin (syngeneic) marrow transplantation for hematologic cancers. J Natl Cancer Inst 76:1269\u20131273","journal-title":"J Natl Cancer Inst"},{"key":"1_CR26_1","volume-title":"King\u2019s American dispensatory","author":"HW Felter","year":"1898\u20131900","unstructured":"Felter HW, Lloyd JU (1898\u20131900) King\u2019s American dispensatory. Ohio Valley Co, Cincinatti"},{"key":"1_CR27_1","first-page":"842","volume":"80","author":"R Fleischer","year":"1880","unstructured":"Fleischer R (1880) Ueber das Vorkommen des sogenannten Bence Jones\u2019 schen Eiweisskorpers im normalen Knochenmark. Arch Pathol Anat Physiol Klin Med 80:842\u2013849","journal-title":"Arch Pathol Anat Physiol Klin Med"},{"key":"1_CR28_1","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood.V69.4.1262.1262","volume":"69","author":"G Gahrton","year":"1987","unstructured":"Gahrton G, Tura S, Flesch M, Gratwohl A, Gravett P, Lucarelli G, Michallet M, Reiffers J, Ringden O, van Lint MT et al (1987) Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow Transplantation. Blood 69:1262\u20131264","journal-title":"Blood"},{"key":"1_CR29_1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archsurg.1928.01140040002001","volume":"16","author":"CF Geschickter","year":"1928","unstructured":"Geschickter CF, Copeland MM (1928) Multiple myeloma. Arch Surg 16:807\u2013863","journal-title":"Arch Surg"},{"key":"1_CR30_1","first-page":"505","volume":"91","author":"H Gestsdottir","year":"2005","unstructured":"Gestsdottir H, Eyjolfsson GI (2005) Myeloma in an archaeological skeleton from Hofstadir in Myvatnssveit. Laeknabladid 91:505\u2013509","journal-title":"Laeknabladid"},{"key":"1_CR31_1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0006-3002(53)90233-9","volume":"10","author":"P Grabar","year":"1953","unstructured":"Grabar P, Williams CA (1953) Method permitting the combined study of the electrophoretic and the immunochemical properties of protein mixtures; application to blood serum. Biochim Biophys Acta 10:193\u2013194","journal-title":"Biochim Biophys Acta"},{"key":"1_CR32_1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/cpt196563298","volume":"6","author":"H Grabstald","year":"1965","unstructured":"Grabstald H, Golbey R (1965) Clinical experiences with thalidomide in patients with cancer. Clin Pharmacol Ther 6:298\u2013302","journal-title":"Clin Pharmacol Ther"},{"key":"1_CR33_1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jfms.2004.12.005","volume":"7","author":"F Hanna","year":"2005","unstructured":"Hanna F (2005) Multiple myelomas in cats. J Feline Med Surg 7:275\u2013287","journal-title":"J Feline Med Surg"},{"key":"1_CR34_1","first-page":"1","volume":"68","author":"JB Harley","year":"1972","unstructured":"Harley JB, Ramanan SV, Kim I, Thiagarajan PV, Chen JH, Gomez R, Koppel D, Hyde F, Gustke S, Krall J (1972) The cyclic use of multiple alkylating agents in multiple myeloma. W V Med J 68:1\u20133","journal-title":"W V Med J"},{"key":"1_CR35_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood.V54.1.13.13","volume":"54","author":"JB Harley","year":"1979","unstructured":"Harley JB, Pajak TF, McIntyre OR, Kochwa S, Cooper MR, Coleman M, Cuttner J (1979) Improved survival of increased-risk myeloma patients on combined triple-alkylating-agent therapy: a study of the CALGB. Blood 54:13\u201322","journal-title":"Blood"},{"key":"1_CR36_1","volume-title":"Die mikroscopisch-chemisch-pathologische untersuchung","author":"JD Heller","year":"1846","unstructured":"Heller JD (1846) Die mikroscopisch-chemisch-pathologische untersuchung. Braumuller & Seidel, Vienna"},{"key":"1_CR37_1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/0009-8981(59)90004-X","volume":"4","author":"JF Heremans","year":"1959","unstructured":"Heremans JF (1959) Immunochemical studies on protein pathology. The immunoglobulin concept. Clin Chim Acta 4:639\u2013646","journal-title":"Clin Chim Acta"},{"key":"1_CR38_1","first-page":"239","volume":"65","author":"JB Herrick","year":"1894","unstructured":"Herrick JB, Hektoen L (1894) Myeloma: report of a case. Med News, Philadelphia 65:239\u2013242","journal-title":"Med News, Philadelphia"},{"key":"1_CR39_1","first-page":"3071","volume":"61","author":"T Hideshima","year":"2001","unstructured":"Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, Adams J, Anderson KC (2001) The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res 61:3071\u20133076","journal-title":"Cancer Res"},{"key":"1_CR40_1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood.V27.3.328.328","volume":"27","author":"JR Holland","year":"1966","unstructured":"Holland JR, Hosley H, Scharlau C, Carbone PP, Frei E III, Brindley CO, Hall TC, Shnider BI, Gold GL, Lasagna L, Owens AH Jr, Miller SP (1966) A controlled trial of urethane treatment in multiple myeloma. Blood 27:328\u2013342","journal-title":"Blood"},{"key":"1_CR41_1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood.V30.1.74.74","volume":"30","author":"B Hoogstraten","year":"1967","unstructured":"Hoogstraten B, Sheehe PR, Cuttner J, Cooper T, Kyle RA, Oberfield RA, Townsend SR, Harley JB, Hayes DM, Costa G, Holland JF (1967) Melphalan in multiple myeloma. Blood 30:74\u201383","journal-title":"Blood"},{"key":"1_CR42_1","first-page":"840","volume":"97","author":"K Ishizaka","year":"1966","unstructured":"Ishizaka K, Ishizaka T, Hornbrook MM (1966) Physicochemical properties of reaginic antibody. V. correlation of reaginic activity with gamma-E-globulin antibody. J Urol 97:840\u2013853","journal-title":"J Urol"},{"key":"1_CR43_1","first-page":"45","volume":"14","author":"O Kahler","year":"1889","unstructured":"Kahler O (1889) Zur symptomatologie des multiplen myeloms: Beobachtung von Albumosurie. Prager Med Wochenschr (Prague) 14:45","journal-title":"Prager Med Wochenschr (Prague)"},{"key":"1_CR44_1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/1097-0142(195603\/04)9:2<262::AID-CNCR2820090210>3.0.CO;2-B","volume":"9","author":"L Korngold","year":"1956","unstructured":"Korngold L, Lipari R (1956) Multiple myeloma proteins. III. The antigenic relationship of Bence Jones proteins to normal gammaglobulin and multiple myeloma serum proteins. Cancer 9:262\u2013272","journal-title":"Cancer"},{"key":"1_CR45_1","first-page":"209","volume":"19","author":"W Kuhne","year":"1883","unstructured":"K\u00fchne (1883) Ueber Hemialbumose im Harn. Z Biol 19:209\u2013227","journal-title":"Z Biol"},{"key":"1_CR46_1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1085\/jgp.35.1.89","volume":"35","author":"HG Kunkel","year":"1951","unstructured":"Kunkel HG, Tiselius A (1951) Electrophoresis of proteins on filter paper. J Gen Physiol 35:89\u2013118","journal-title":"J Gen Physiol"},{"key":"1_CR47_1","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","volume":"64","author":"RA Kyle","year":"1978","unstructured":"Kyle RA (1978) Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med 64:814\u2013826","journal-title":"Am J Med"},{"key":"1_CR48_1","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1046\/j.1365-2141.2000.02318.x","volume":"111","author":"RA Kyle","year":"2000","unstructured":"Kyle RA (2000) Multiple myeloma: an odyssey of discovery. Br J Haematol 111:1035\u20131044","journal-title":"Br J Haematol"},{"key":"1_CR49_1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1365-2141.2001.02962.x","volume":"115","author":"RA Kyle","year":"2001","unstructured":"Kyle RA (2001) Henry Bence Jones \u2014 physician, chemist, scientist and biographer: a man for all seasons. Br J Haematol 115:13\u201318","journal-title":"Br J Haematol"},{"key":"1_CR50_1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/1097-0142(197402)33:2<533::AID-CNCR2820330231>3.0.CO;2-Z","volume":"33","author":"BJ Lee","year":"1974","unstructured":"Lee BJ, Sahakian G, Clarkson BD, Krakoff IH (1974) Proceedings: combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU. Cancer 33:533\u2013538","journal-title":"Cancer"},{"key":"1_CR51_1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0140-6736(62)92665-X","volume":"1","author":"W Lenz","year":"1962","unstructured":"Lenz W (1962) Thalidomide and congenital abnormalities. Lancet 1:45","journal-title":"Lancet"},{"key":"1_CR52_1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/00000441-194710000-00009","volume":"214","author":"AB Lerner","year":"1947","unstructured":"Lerner AB, Watson CJ (1947) Studies of cryoglobulins; unusual purpura associated with the presence of a high concentration of cryoglobulin (cold precipitable serum globulin). Am J Med Sci 214:410\u2013415","journal-title":"Am J Med Sci"},{"key":"1_CR53_1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1084\/jem.70.4.399","volume":"70","author":"AB Longsworth","year":"1939","unstructured":"Longsworth AB, Shedlovsky T, MacInnes DA (1939) Electrophoretic patterns of normal and pathological human blood serum and plasma. J Exp Med 70:399\u2013413","journal-title":"J Exp Med"},{"key":"1_CR54_1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/095952875003300113","volume":"33","author":"W Macintyre","year":"1850","unstructured":"Macintyre W (1850) Case of mollities and fragilitas ossium, accompanied with urine strongly charged with animal matter. Med Chir Trans 33:211\u2013232","journal-title":"Med Chir Trans"},{"key":"1_CR55_1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF02111311","volume":"30","author":"T Marschalko","year":"1895","unstructured":"Marschalko T (1895) Ueber die sogenannten plasmazellen, ein Beitrage zur Kenntniss der Herkunft der entzundlichen infiltrationszellen. Arch Dermatol Syph 30:241","journal-title":"Arch Dermatol Syph"},{"key":"1_CR56_1","first-page":"257","volume":"16","author":"RE Mass","year":"1962","unstructured":"Mass RE (1962) A comparison of the effect of prednisone and a placebo in the treatment of multiple myeloma. Cancer Chemother Rep 16:257\u2013259","journal-title":"Cancer Chemother Rep"},{"issue":"5","key":"1_CR57_1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/mpo.2950130502","volume":"13","author":"OR McIntyre","year":"1985","unstructured":"McIntyre OR, Pajak TF, Kyle RA, Cornwell GG, Leone L (1985) Response rate and survival in myeloma patients receiving prednisone alone. Med Pediatr Oncol 13(5):239\u2013243","journal-title":"Med Pediatr Oncol"},{"key":"1_CR58_1","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0140-6736(83)90739-0","volume":"2","author":"TJ McElwain","year":"1983","unstructured":"McElwain TJ, Powles RL (1983) High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet 2:822\u2013824","journal-title":"Lancet"},{"key":"1_CR59_1","first-page":"447","volume":"50","author":"D Morse","year":"1974","unstructured":"Morse D, Dailey RC, Bunn J (1974) Prehistoric multiple myeloma. Bull New York Acad Med 50:447\u2013458","journal-title":"Bull New York Acad Med"},{"key":"1_CR60_1","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1200\/JCO.1998.16.12.3832","volume":"16","author":"Myeloma Trialists\u2019 Collaborative Group","year":"1998","unstructured":"Myeloma Trialists\u2019 Collaborative Group (1998) Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. J Clin Oncol 16:3832\u20133842","journal-title":"J Clin Oncol"},{"key":"1_CR61_1","first-page":"197","volume":"16","author":"AG Nerlich","year":"2006","unstructured":"Nerlich AG, Rohrbach H, Bachmeier B, Zink A (2006) Malignant tumors in two ancient populations: an approach to historical tumor epidemiology. Oncol Rep 16:197\u2013202","journal-title":"Oncol Rep"},{"key":"1_CR62_1","first-page":"79","volume":"6","author":"Nothnagel","year":"1893","unstructured":"Nothnagel H (1893) Hofrath Otto Kahler. Wien Klin Wochenschr (Wien) 6:79\u201380","journal-title":"Wien Klin Wochenschr (Wien)"},{"key":"1_CR63_1","unstructured":"Obituary (1873). Henry Bence Jones, M.D., F.R.C.P., F.R.S. Med Times Gaz 1:505"},{"key":"1_CR64_1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cpt196563292","volume":"6","author":"KB Olson","year":"1965","unstructured":"Olson KB, Hall TC, Horton J, Khung CL, Hosley HF (1965) Thalidomide (N-Phthaloylglutamimide) in the treatment of advanced cancer. Clin Pharmacol Ther 6:292\u2013297","journal-title":"Clin Pharmacol Ther"},{"key":"1_CR65_1","first-page":"4342","volume":"58","author":"RZ Orlowski","year":"1998","unstructured":"Orlowski RZ, Eswara JR, Lafond-Walker A, Grever MR, Orlowski M, Dang CV (1998) Tumor growth inhibition induced in a murine model of human Burkitt\u2019s lymphoma by a proteasome inhibitor. Cancer Res 58:4342\u20134348","journal-title":"Cancer Res"},{"key":"1_CR66_1","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1200\/JCO.2002.01.133","volume":"20","author":"RZ Orlowski","year":"2002","unstructured":"Orlowski RZ, Stinchcombe TE, Mitchell BS, Shea TC, Baldwin AS, Stahl S, Adams J, Esseltine DL, Elliott PJ, Pien CS, Guerciolini R, Anderson JK, Depcik-Smith ND, Bhagat R, Lehman MJ, Novick SC, O\u2019Connor OA, Soignet SL (2002) Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies. J Clin Oncol 20:4420\u20134427","journal-title":"J Clin Oncol"},{"key":"1_CR67_1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000206984","volume":"68","author":"EF Osserman","year":"1982","unstructured":"Osserman EF, DiRe LB, DiRe J, Sherman WH, Hersman JA, Storb R (1982) Identical twin marrow transplantation in multiple myeloma. Acta Haematol 68:215\u2013223","journal-title":"Acta Haematol"},{"key":"1_CR68_1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jama.1928.02690370023011","volume":"90","author":"WA Perlzweig","year":"1928","unstructured":"Perlzweig WA, Delrue G, Geschicter C (1928) Hyperproteinemia associated with multiple myelomas: report of an unusual case. JAMA 90:755\u2013757","journal-title":"JAMA"},{"key":"1_CR69_1","first-page":"631","volume":"16","author":"GA Peters","year":"1941","unstructured":"Peters GA, Horton BT (1941) Allergic purpura with special reference to hypersensitiveness to cold. Mayo Clin Proc 16:631\u2013636","journal-title":"Mayo Clin Proc"},{"key":"1_CR70_1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1353\/pbm.1993.0037","volume":"36","author":"FW Putnam","year":"1993","unstructured":"Putnam FW (1993) Henry Bence Jones: the best chemical doctor in London. Perspect Biol Med 36:565\u2013579","journal-title":"Perspect Biol Med"},{"key":"1_CR71_1","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1182\/blood-2005-07-2817","volume":"106","author":"SV Rajkumar","year":"2005","unstructured":"Rajkumar SV, Hayman SR, Lacy MQ, Dispenzieri A, Geyer SM, Kabat B, Zeldenrust SR, Kumar S, Greipp PR, Fonseca R, Lust JA, Russell SJ, Kyle RA, Witzig TE, Gertz MA (2005) Combination therapy with lenalidomide plus dexamethasone (Rev\/Dex) for newly diagnosed myeloma. Blood 106:4050\u20134053","journal-title":"Blood"},{"key":"1_CR72_1","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1182\/blood-2002-03-0996","volume":"100","author":"PG Richardson","year":"2002","unstructured":"Richardson PG, Schlossman RL, Weller E, Hideshima T, Mitsiades C, Davies F, LeBlanc R, Catley LP, Doss D, Kelly K, McKenney M, Mechlowicz J, Freeman A, Deocampo R, Rich R, Ryoo JJ, Chauhan D, Balinski K, Zeldis J, Anderson KC (2002) Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma. Blood 100:3063\u20133067","journal-title":"Blood"},{"key":"1_CR73_1","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1056\/NEJMoa030288","volume":"348","author":"PG Richardson","year":"2003","unstructured":"Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, Esseltine DL, Kauffman M, Adams J, Schenkein DP, Anderson KC (2003) A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 348:2609\u20132617 [see comment]","journal-title":"N Engl J Med"},{"key":"1_CR74_1","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa043445","volume":"352","author":"PG Richardson","year":"2005","unstructured":"Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, San-Miguel JF, Blade J, Boccadoro M, Cavenagh J, Dalton WS, Boral AL, Esseltine DL, Porter JB, Schenkein D, Anderson KC (2005) Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 352:2487\u20132498","journal-title":"N Engl J Med"},{"key":"1_CR75_1","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1182\/blood-2006-04-015909","volume":"108","author":"PG Richardson","year":"2006","unstructured":"Richardson PG, Blood E, Mitsiades CS, Jagannath S, Zeldenrust SR, Alsina M, Schlossman RL, Rajkumar SV, Desikan KR, Hideshima T, Munshi NC, Kelly-Colson K, Doss D, McKenney ML, Gorelik S, Warren D, Freeman A, Rich R, Wu A, Olesnyckyj M, Wride K, Dalton WS, Zeldis J, Knight R, Weller E, Anderson KC (2006) A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma. Blood 108:3458\u20133464","journal-title":"Blood"},{"key":"1_CR76_1","first-page":"262","volume":"2","author":"J Rosenbloom","year":"1919","unstructured":"Rosenbloom J (1919) An appreciation of Henry Bence Jones, M.D., F.R.S. (1814-1873). Ann Med Hist 2:262\u2013264","journal-title":"Ann Med Hist"},{"key":"1_CR77_1","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/clinchem\/33.9.1687","volume":"33","author":"L Rosenfeld","year":"1987","unstructured":"Rosenfeld L (1987) Henry Bence Jones (1813\u20131873): the best \u201cchemical doctor\u201d in London. Clin Chem 33:1687\u20131692","journal-title":"Clin Chem"},{"key":"1_CR78_1","first-page":"1001","volume":"4","author":"N Rosenthal","year":"1938","unstructured":"Rosenthal N, Vogel P (1938) Value of the sternal puncture in the diagnosis of multiple myeloma. Mt Sinai J Med 4:1001\u20131019","journal-title":"Mt Sinai J Med"},{"key":"1_CR79_1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/(SICI)1096-8644(199802)105:2<241::AID-AJPA10>3.0.CO;2-0","volume":"105","author":"BM Rothschild","year":"1998","unstructured":"Rothschild BM, Hershkovitz I, Dutour O (1998) Clues potentially distinguishing lytic lesions of multiple myeloma from those of metastatic carcinoma. Am J Phys Anthropol 105:241\u2013250","journal-title":"Am J Phys Anthropol"},{"key":"1_CR80_1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1084\/jem.121.1.171","volume":"121","author":"DS Rowe","year":"1965","unstructured":"Rowe DS, Fahey JL (1965) A new class of human immunoglobulins. I. A unique myeloma protein. J Exp Med 121:171\u2013184","journal-title":"J Exp Med"},{"key":"1_CR81_1","first-page":"179","volume":"51","author":"SE Salmon","year":"1967","unstructured":"Salmon SE, Shadduck RK, Schilling A (1967) Intermittent high-dose prednisone (NSC-10023) therapy for multiple myeloma. Cancer Chemother Rep 51:179\u2013187","journal-title":"Cancer Chemother Rep"},{"key":"1_CR82_1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","volume":"341","author":"S Singhal","year":"1999","unstructured":"Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B (1999) Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 341:1565\u20131571 [see comment] [erratum appears in N Engl J Med 3 Feb 2000; 342(5):364]","journal-title":"N Engl J Med"},{"key":"1_CR83_1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/095952874402700129","volume":"27","author":"S Solly","year":"1844","unstructured":"Solly S (1844) Remarks on the pathology of mollities ossium with cases. Med Chir Trans 27:435\u2013461","journal-title":"Med Chir Trans"},{"key":"1_CR84_1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000096757","volume":"153","author":"DP Steensma","year":"2007","unstructured":"Steensma DP, Kyle RA (2007) A history of the kidney in plasma cell disorders. Contrib Nephrol 153:5\u201324","journal-title":"Contrib Nephrol"},{"key":"1_CR85_1","volume-title":"Paleopathological diagnosis and interpretation","author":"T Steinbock","year":"1976","unstructured":"Steinbock T (1976) Paleopathological diagnosis and interpretation. CC Thomas, Springfield"},{"key":"1_CR86_1","unstructured":"Stephens JL (1994) Arrowroot \u2014 Maranta arundinacea L. In: Fact Sheet HS-542. A series of the Horticultural Sciences Department, Florida Cooperative Extension Service, Institute of Food and Agricultural Services, University of Florida, Gainsville"},{"key":"1_CR87_1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJM195709122571102","volume":"257","author":"ED Thomas","year":"1957","unstructured":"Thomas ED, Lochte HL Jr, Lu WC, Ferrebee JW (1957) Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 257:491\u2013496","journal-title":"N Engl J Med"},{"key":"1_CR88_1","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1042\/bj0311464","volume":"31","author":"A Tiselius","year":"1937","unstructured":"Tiselius A (1937a) Electrophoresis of serum globulin. II. Electrophoretic analysis of normal and immune sera. Biochem J 31:1464\u20131477","journal-title":"Biochem J"},{"key":"1_CR89_1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1039\/tf9373300524","volume":"33","author":"A Tiselius","year":"1937","unstructured":"Tiselius A (1937b) A new apparatus for electrophoretic analysis of colloidal mixtures. T Faraday Soc 33:524","journal-title":"T Faraday Soc"},{"key":"1_CR90_1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1084\/jem.69.1.119","volume":"69","author":"A Tiselius","year":"1939","unstructured":"Tiselius A, Kabat EA (1939) Electrophoretic study of immune sera and purified antibody preparation. J Exp Med 69:119\u2013131","journal-title":"J Exp Med"},{"key":"1_CR91_1","first-page":"1113","volume":"49","author":"EA von Behring","year":"1890","unstructured":"von Behring EA, Kisato S (1890) Ueber das Zustandekommen der Diphtherie-Immunitat und der Tetanus-Immunitat bei Theieren. Dtsch Med Wochenschr 49:1113\u20131114","journal-title":"Dtsch Med Wochenschr"},{"key":"1_CR92_1","first-page":"211","volume":"56","author":"J Waldenstrom","year":"1960\u20131961","unstructured":"Waldenstrom J (1960\u20131961) Studies on conditions associated with disturbed gamma globulin formation (gammopathies). Harvey Lect 56:211\u2013231","journal-title":"Harvey Lect"},{"key":"1_CR93_1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/BF02933794","volume":"11","author":"W Waldeyer","year":"1875","unstructured":"Waldeyer W (1875) Ueber bindegewebszellen. Arch Microbiol Anat 11:176\u2013194","journal-title":"Arch Microbiol Anat"},{"key":"1_CR94_1","first-page":"186","volume":"23","author":"H Weber","year":"1867","unstructured":"Weber H (1867) Mollities ossium, doubtful whether carcinomatous or syphilitic. Trans Pathol Soc Lond 23:186\u2013187","journal-title":"Trans Pathol Soc Lond"},{"key":"1_CR95_1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/path.1700050106","volume":"5","author":"FP Weber","year":"1898","unstructured":"Weber FP (1898) General lymphadenomatosis of bones, one form of \u2018multiple myeloma\u2019. J Pathol 5:59\u201364","journal-title":"J Pathol"},{"key":"1_CR96_1","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/00000441-190310000-00009","volume":"126","author":"FP Weber","year":"1903","unstructured":"Weber FP, Hutchinson R, Macleod JJR (1903) Multiple myeloma (myelomatosis), with Bence-Jones protein in the urine (myelopathic albumosuria of Bradshaw, Kahler\u2019s disease). Am J Med Sci 126:644\u2013665","journal-title":"Am J Med Sci"},{"key":"1_CR97_1","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMoa070596","volume":"357","author":"DM Weber","year":"2007","unstructured":"Weber DM, Chen C, Niesvizky R, Wang M, Belch A, Stadtmauer EA, Siegel D, Borrello I, Rajkumar SV, Chanan-Khan AA, Lonial S, Yu Z, Patin J, Olesnyckyj M, Zeldis JB, Knight RD (2007) Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America. N Engl J Med 357:2133\u20132142","journal-title":"N Engl J Med"},{"key":"1_CR98_1","first-page":"1611","volume":"1","author":"C Wells","year":"1964","unstructured":"Wells C (1964) Two mediaeval cases of malignant disease. BMJ 1:1611\u20131612","journal-title":"BMJ"},{"key":"1_CR99_1","first-page":"156","volume":"52","author":"MM Wintrobe","year":"1933","unstructured":"Wintrobe MM, Buell MV (1933) Hyperproteinemia associated with multiple myeloma, with report of a case in which an extraordinary hyperproteinemia was associated with thrombosis of the retinal veins and symptoms suggesting Raynaud\u2019s disease. Bull Johns Hopkins Hosp 52:156\u2013165","journal-title":"Bull Johns Hopkins Hosp"},{"key":"1_CR100_1","first-page":"137","volume":"15","author":"JH Wright","year":"1900","unstructured":"Wright JH (1900) A case of multiple myeloma. Trans Assoc Am Physician 15:137\u2013147","journal-title":"Trans Assoc Am Physician"},{"key":"1_CR101_1","first-page":"4273","volume":"19","author":"A Zink","year":"1999","unstructured":"Zink A, Rohrbach H, Szeimies U, Hagedorn HG, Haas CJ, Weyss C, Bachmeier B, Nerlich AG (1999) Malignant tumors in an ancient Egyptian population. Anticancer Res 19:4273\u20134277","journal-title":"Anticancer Res"}],"container-title":["Recent Results in Cancer Research","Multiple Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-85772-3_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:17:48Z","timestamp":1674087468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-540-85772-3_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9783540857716","9783540857723"],"references-count":101,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-85772-3_1","relation":{},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]},"assertion":[{"value":"19 March 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}